A detailed history of Inspire Investing, LLC transactions in Geron Corp stock. As of the latest transaction made, Inspire Investing, LLC holds 159,754 shares of GERN stock, worth $637,418. This represents 0.08% of its overall portfolio holdings.

Number of Shares
159,754
Previous 82,660 93.27%
Holding current value
$637,418
Previous $350,000 107.14%
% of portfolio
0.08%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$4.17 - $4.99 $321,481 - $384,699
77,094 Added 93.27%
159,754 $725,000
Q2 2024

Aug 12, 2024

SELL
$3.1 - $5.09 $78,302 - $128,568
-25,259 Reduced 23.41%
82,660 $350,000
Q1 2024

May 07, 2024

SELL
$1.75 - $3.44 $128,537 - $252,668
-73,450 Reduced 40.5%
107,919 $356,000
Q4 2023

Feb 12, 2024

BUY
$1.74 - $2.31 $61,916 - $82,199
35,584 Added 24.41%
181,369 $382,000
Q3 2023

Oct 26, 2023

BUY
$2.11 - $3.28 $307,606 - $478,174
145,785 New
145,785 $309,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.51B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.